BVI-007

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBVI-007
Drug Alias NameBVI-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiovascular
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiovascular
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionStroke

Other Information

ATC CodeN/A
Related LinksN/A